Stockreport

BRIEF-Hemispherx Biopharma Q1 Operating Loss Per Share $0.07 [Reuters]

HEMISPHERX BIOPHARMA  (HEB) 
NASDAQ:AMEX Investor Relations: hemispherx.net/mobile/investor-relations.php
PDF BRIEF-Hemispherx Biopharma Q1 Operating Loss Per Share $0.07 | Reuters Reuters Staff 1 Min Read May 16 (Reuters) - Hemispherx Biopharma Inc: * HEMISPHERX BIOPHARMA REPOR [Read more]